🔎 Trials Near Me

Beranda › Penyakit Ginjal Kronis › Illinois

Uji klinis Penyakit Ginjal Kronis di Illinois

17 studi untuk Penyakit Ginjal Kronis mencari peserta di lokasi di Illinois.

Kota di Illinois

Teks studi resmi (Bahasa Inggris)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Accellacare - DuPage, Lombard
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Champaign
  • Research Site, Maywood
  • Research Site, Rockford
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06742723

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

  • Comprehensive Transplant Center, Chicago
Menerima pesertaStudi observasional
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05106387

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Oak Brook
  • Research Site, Rockford
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07624305

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07107945

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Research by Design, LLC - Internal Medicine, Chicago
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Champaign
  • Research Site, Chicago
  • Research Site, Chicago
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07753993

Breakthrough - T1DM and Chronic Kidney Disease

  • The University of Chicago, Chicago
Menerima pesertaFase 1/2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07592000

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Menerima pesertaFase awal 1
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06430684

Study of BHV-1400 in IgA Nephropathy

  • Site-009, Hinsdale
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07054684

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

  • Northwestern Memorial Hospital, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT01644903

Empagliflozin Treatment in Kidney Transplant Recipients

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
Menerima pesertaFase 4
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06013865

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04334707

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 1/2
Usia 40 hingga 70 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06878560

Transformative Research in Diabetic Nephropathy

  • Northwestern University, Chicago
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT02986984

Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

  • University of Chicago Medical Center, Chicago
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT06397456

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.